HomeInsightsStock Comparison

J B Chemicals Pharmaceuticals Ltd vs Jubilant Pharmova Ltd Stock Comparison

J B Chemicals Pharmaceuticals Ltd vs Jubilant Pharmova Ltd Stock Comparison

Last Updated on: Jun 25, 2025

Key Highlights

  • The Latest Trading Price of J B Chemicals & Pharmaceuticals Ltd is ₹ 1811 as of 25 Jun 09:21.
  • The P/E Ratio of J B Chemicals & Pharmaceuticals Ltd changed from 14.4 on March 2020 to 46.3 on March 2024 . This represents a CAGR of 26.31% over 5 yearsThe P/E Ratio of Jubilant Pharmova Ltd changed from 4.4 on March 2020 to 116.5 on March 2024 . This represents a CAGR of 92.56% over 5 years.
  • The Market Cap of J B Chemicals & Pharmaceuticals Ltd changed from ₹ 3928 crore on March 2020 to ₹ 25598 crore on March 2024 . This represents a CAGR of 45.48% over 5 yearsThe Market Cap of Jubilant Pharmova Ltd changed from ₹ 3964 crore on March 2020 to ₹ 9056 crore on March 2024 . This represents a CAGR of 17.97% over 5 years.
  • The revenue of J B Chemicals & Pharmaceuticals Ltd for the Mar '25 is ₹ 963.96 crore as compare to the Dec '24 revenue of ₹ 971.49 crore. This represent the decline of -0.78% The revenue of Jubilant Pharmova Ltd for the Mar '25 is ₹ 1940 crore as compare to the Dec '24 revenue of ₹ 1830 crore. This represent the growth of 6%.
  • The ebitda of J B Chemicals & Pharmaceuticals Ltd for the Mar '25 is ₹ 240.92 crore as compare to the Dec '24 ebitda of ₹ 262.51 crore. This represent the decline of -8.22% The ebitda of Jubilant Pharmova Ltd for the Mar '25 is ₹ 353.9 crore as compare to the Dec '24 ebitda of ₹ 277.4 crore. This represent the growth of 27.58%.
  • The net profit of J B Chemicals & Pharmaceuticals Ltd changed from ₹ 142.32 crore to ₹ 145.69 crore over 8 quarters. This represents a CAGR of 1.18% The net profit of Jubilant Pharmova Ltd changed from ₹ 6 crore to ₹ 151.3 crore over 8 quarters. This represents a CAGR of 402.16% .
  • The Dividend Payout of J B Chemicals & Pharmaceuticals Ltd changed from 31.71 % on March 2020 to 34.99 % on March 2024 . This represents a CAGR of 1.99% over 5 yearsThe Dividend Payout of Jubilant Pharmova Ltd changed from 24.8 % on March 2020 to 251.58 % on March 2024 . This represents a CAGR of 58.94% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About J B Chemicals & Pharmaceuticals Ltd

  • J B Chemicals & Pharmaceuticals Limited (JBC) was originally promoted and incorporated in Maharashtra by J B Mody as J B Mody Chemicals & Pharmaceuticals on December 18, 1976.
  • The Company is engaged in the business of manufacturing and marketing of diverse range of pharmaceuticals formulations, herbal remedies and Active Pharmaceutical Ingredients (APIs).
  • The company has manufacturing units at Thane, Belapur, Ankleshwar, Panoli and Daman.
  • The bulk drug plant at Panoli and formulation plant at Daman became operational in Apr.'95.
  • Products like metrogyl, rantac (a ranitidine-based formulation), and nicardia (a cardiac care medicine) form a significant part of the company's sales.

About Jubilant Pharmova Ltd

  • Jubilant Pharmova Limited, (Formerly known as Jubilant Life Sciences Limited), is an integrated global pharmaceutical and life sciences company engaged in Pharmaceuticals, Life Science Ingredients and Drug Discovery Solutions.
  • The Company is engaged in pharmaceuticals, contract research and development services and proprietary novel drugs.
  • The pharmaceuticals segment, through wholly owned subsidiary Jubilant Pharma Limited, is engaged in manufacture and supply of Active Pharmaceutical Ingredients (APIs), Solid Dosage Formulations, Radiopharmaceuticals, Allergy Therapy Products and Contract Manufacturing of Sterile Injectables and Non-Sterile Products through 6 US FDA approved manufacturing facilities in India, USA and Canada with a network of over 48 radiopharmacies in the USA. The contract research and development segment provides drug discovery and development services as well as clinical data software and service solutions.

J B Chemicals & Pharmaceuticals Ltd News Hub

News

J B Chemicals receives USFDA approval for Amitriptyline Hydrochloride Tablets

J B Chemicals & Pharmaceuticals has received approval from United States Food and Drug Adm...

Read more

24 Jun 2025 18:31

News

J B Chemicals & Pharmaceuticals allots 85,390 equity shares under ESOS

J B Chemicals & Pharmaceuticals has allotted 85,390 equity shares under ESOS. Consequently...

Read more

11 Jun 2025 18:10

News

J B Chemicals & Pharmaceuticals allots 1.12 lakh equity shares under ESOS

J B Chemicals & Pharmaceuticals has allotted 112,990 fully paid up equity shares of Re. 1/...

Read more

05 Jun 2025 12:59

News

Board of J B Chemicals & Pharmaceuticals recommends final dividend

J B Chemicals & Pharmaceuticals announced that the Board of Directors of the Company at it...

Read more

15 May 2025 09:45

News

J B Chemicals & Pharmaceuticals allots 65,686 equity shares under ESOS

J B Chemicals & Pharmaceuticals has allotted 65,686 equity shares under ESOS on 05 May 202...

Read more

06 May 2025 09:12

News

J B Chemicals & Pharmaceuticals schedules board meeting

J B Chemicals & Pharmaceuticals will hold a meeting of the Board of Directors of the Compa...

Read more

22 Apr 2025 17:20

Jubilant Pharmova Ltd News Hub

News

Board of Jubilant Pharmova recommends final dividend

Jubilant Pharmova announced that the Board of Directors of the Company at its meeting held...

Read more

16 May 2025 14:12

News

Jubilant Pharmova jumps after reporting turnaround Q4 performance

Revenue from operations increased 9.7% YoY to Rs 1,915.80 crore in Q4 FY25. The company re...

Read more

16 May 2025 16:07

News

Jubilant Pharmova to hold board meeting

Jubilant Pharmova will hold a meeting of the Board of Directors of the Company on 16 May 2...

Read more

02 May 2025 13:52

News

Jubilant Pharmova arm gets EIR from USFDA for Maryland facility

The US Food and Drug Administration (USFDA) had classified the inspection as voluntary act...

Read more

13 Mar 2025 10:18

News

Volumes spurt at Jubilant Pharmova Ltd counter

K E C International Ltd, Indian Bank, J B Chemicals & Pharmaceuticals Ltd, Birla Corporati...

Read more

13 Mar 2025 11:00

News

Jubilant Pharmova announces acquisition of 80% stake in JASMIN

Jubilant Biosys Innovative Research Services, Singapore (JBIRSPL), a subsidiary of Jubilan...

Read more

29 Jan 2025 09:03

SWOT Analysis Of Jubilant Pharmova Ltd

Strength

3

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of J B Chemicals & Pharmaceuticals Ltd

Strength

4

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Jubilant Pharmova Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for J B Chemicals & Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of J B Chemicals & Pharmaceuticals Ltd and Jubilant Pharmova Ltd

Which company has a larger market capitalization, J B Chemicals & Pharmaceuticals Ltd or Jubilant Pharmova Ltd?

Market cap of J B Chemicals & Pharmaceuticals Ltd is 28,071 Cr while Market cap of Jubilant Pharmova Ltd is 17,846 Cr

What are the key factors driving the stock performance of J B Chemicals & Pharmaceuticals Ltd and Jubilant Pharmova Ltd?

The stock performance of J B Chemicals & Pharmaceuticals Ltd and Jubilant Pharmova Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for J B Chemicals & Pharmaceuticals Ltd and Jubilant Pharmova Ltd?

As of June 25, 2025, the J B Chemicals & Pharmaceuticals Ltd stock price is INR ₹1798.8. On the other hand, Jubilant Pharmova Ltd stock price is INR ₹1120.3.

How do dividend payouts of J B Chemicals & Pharmaceuticals Ltd and Jubilant Pharmova Ltd compare?

To compare the dividend payouts of J B Chemicals & Pharmaceuticals Ltd and Jubilant Pharmova Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions